Annals of Clinical and Translational Neurology (Sep 2021)

Wearable myoelectric interface enables high‐dose, home‐based training in severely impaired chronic stroke survivors

  • Na‐Teng Hung,
  • Vivek Paul,
  • Prashanth Prakash,
  • Torin Kovach,
  • Gene Tacy,
  • Goran Tomic,
  • Sangsoo Park,
  • Tyler Jacobson,
  • Alix Jampol,
  • Pooja Patel,
  • Anya Chappel,
  • Erin King,
  • Marc W. Slutzky

DOI
https://doi.org/10.1002/acn3.51442
Journal volume & issue
Vol. 8, no. 9
pp. 1895 – 1905

Abstract

Read online

Abstract Background High‐intensity occupational therapy can improve arm function after stroke, but many people lack access to such therapy. Home‐based therapies could address this need, but they don’t typically address abnormal muscle co‐activation, an important aspect of arm impairment. An earlier study using lab‐based, myoelectric computer interface game training enabled chronic stroke survivors to reduce abnormal co‐activation and improve arm function. Here, we assess feasibility of doing this training at home using a novel, wearable, myoelectric interface for neurorehabilitation training (MINT) paradigm. Objective Assess tolerability and feasibility of home‐based, high‐dose MINT therapy in severely impaired chronic stroke survivors. Methods Twenty‐three participants were instructed to train with the MINT and game for 90 min/day, 36 days over 6 weeks. We assessed feasibility using amount of time trained and game performance. We assessed tolerability (enjoyment and effort) using a customized version of the Intrinsic Motivation Inventory at the conclusion of training. Results Participants displayed high adherence to near‐daily therapy at home (mean of 82 min/day of training; 96% trained at least 60 min/day) and enjoyed the therapy. Training performance improved and co‐activation decreased with training. Although a substantial number of participants stopped training, most dropouts were due to reasons unrelated to the training paradigm itself. Interpretation Home‐based therapy with MINT is feasible and tolerable in severely impaired stroke survivors. This affordable, enjoyable, and mobile health paradigm has potential to improve recovery from stroke in a variety of settings. Clinicaltrials.gov: NCT03401762.